Polyclonal Antibodies Market
According to Intent Market Research, the Polyclonal Antibodies Market is expected to grow from USD 1.7 Billion in 2024-e at a CAGR of 6.3% to touch USD 2.4 Billion by 2030. The Polyclonal Antibodies Market is dominated by key players such as Merck KGaA, Abcam plc, Cell Signaling Technology, Inc., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., and GenScript Biotech Corporation